DDB and Pfizer NZ team up to help cancer patients

  • Advertising
  • January 31, 2018
  • StopPress Team
DDB and Pfizer NZ team up to help cancer patients

DDB and pharmaceutical company Pfizer New Zealand have created an app to help advanced stage renal cancer patients manage their treatment.

Called ‘Caremate’, the digital platform makes it easier to keep to what can be complex and difficult to follow treatment schedules.

It also helps patients monitor their condition regardless of where they are, ultimately helping achieve better treatment outcomes.

The app and its support pack work together to remind patients to take their medication, record their blood pressure, mood and symptoms on a daily basis while tracking their treatment. It also provides guidance on how to deal with symptoms they may be experiencing.

Healthcare professionals can access the data from the app during patient visits to obtain a more accurate overview of how the treatment has been working and a better understanding of how to optimise it.

DDB Digital New Zealand creative director Haydn Kerr says while a creative agency developing a digital app to support patients taking a medicine may sound unusual, using creativity and empathy to solve a medical problem makes a world of sense.

“At DDB we believe our role is to create real-world solutions for the businesses we serve. Caremate is an innovative new programme that does just that, and we’re proud to work with Pfizer NZ to bring it to life for those in need.”

Caremate has already been adopted by New Zealand patients and is starting to be used in Australia. 

A video explaining the app can be seen here.

This is a community discussion forum. Comment is free but please respect our rules:

  1. Don’t be abusive or use sweary type words
  2. Don’t break the law: libel, slander and defamatory comments are forbidden
  3. Don’t resort to name-calling, mean-spiritedness, or slagging off
  4. Don’t pretend to be someone else.

If we find you doing these things, your comments will be edited without recourse and you may be asked to go away and reconsider your actions.
We respect the right to free speech and anonymous comments. Don’t abuse the privilege.

Whittaker's divides the court of public opinion – but all for a good cause

  • Advertising
  • February 22, 2019
  • Caitlin Salter
Whittaker's divides the court of public opinion – but all for a good cause

On Monday, Whittaker’s launched its latest novelty chocolate-lolly mash up with a chocolatey answer to retro bakesale treat coconut ice. The Coconut Ice Surprise chocolate has a twist though, 20c from each block goes to Plunket – a charity which New Zealanders agree is a worthy cause. However, to relate the chocolate to the charity, Whittaker's has built the campaign around baby gender reveal parties, causing a backlash from the public who argue gender norms have expanded beyond blue for boys and pink for girls.

Read more
Next page
Results for

StopPress provides essential industry news and intelligence, updated daily. And the digital newsletter delivers the latest news to your inbox twice a week — for free!

©2009–2019 ICG Media. All rights reserved.
Use of this site constitutes acceptance of our Privacy policy.


Contact Vernene Medcalf at +64 21 628 200 to advertise in StopPress.

View Media Kit